Bobby Gaspar Insider Profile

4 Followers
Bobby Gaspar, CEO, Director at Orchard Therapeutics, holds 0.00 shares in Orchard Therapeutics (Ticker: ORTX).
tipranks
Bobby Gaspar

Bobby Gaspar
Orchard Therapeutics (ORTX)
CEO, Director

Not Ranked
Bobby Gaspar has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Bobby Gaspar does not currently own shares as a corporate insider.
A breakdown of Bobby Gaspar's holdings

Insider Roles

Bobby Gaspar does not currently hold a role as a corporate insider.
Roles that Bobby Gaspar holds in companies

Most Profitable Insider Trade

Stock:
Orchard Therapeutics
(ORTX)
Rating:Informative Buy
Date:Apr 05, 2022 - Apr 05, 2023
Return:-31.30%
The most profitable trade made by Bobby Gaspar

Bobby Gaspar's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ORTX
Orchard Therapeutics
Jan 24, 2024
Uninformative Sell
$0.00
ORTX
is no longer traded
Success Rate for
ORTX
0 out of 1 profitable transactions on
ORTX
0%
Average Return for
ORTX
Average return per transaction on
ORTX
-31.30%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 12, 2021
Uninformative Buy
$0.00
-
$0.00
Apr 05, 2022
Informative Buy
$10.95K
-
$0.73
-31.30%
Jan 12, 2021
Uninformative Sell
$22.92K
-
$6.72
Jan 24, 2024
Uninformative Sell
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Bobby Gaspar's performance on stock

Bobby Gaspar insider profile FAQ

What is the percentage of profitable transactions made by Bobby Gaspar?
The percentage of profitable transactions made by Bobby Gaspar is ―.
    What is the average return per transaction made by Bobby Gaspar?
    The average return per transaction made by Bobby Gaspar is ―.
      What stocks does Bobby Gaspar hold?
      Bobby Gaspar holds: ORTX stocks.
        What was Bobby Gaspar’s latest transaction?
        Bobby Gaspar latest transaction was an Uninformative Sell of ―.
          What was Bobby Gaspar's most profitable transaction?
          Bobby Gaspar’s most profitable transaction was an Informative Buy of ORTX stock on April 5, 2022. The return on the trade was -31.30%.
            What is Bobby Gaspar's role in Orchard Therapeutics?
            Bobby Gaspar's role in Orchard Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.